🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Havrix®

Found 20 matching trials

Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population

PHASE3

The primary objective is to assess the systemic and local safety profile of...

Status

Completed

Location

Research Institute for Tropical Medicine

Start Date

2010-03

Trial ID

NCT01041573

Treatments Being Tested

IC51 Japanese Encephalitis Havrix®720 Prevnar

Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age

PHASE3

This is a study to evaluate the immunogenicity and safety of GSK Biological...

Status

Completed

Location

GSK Investigational Site

Start Date

2003-09-11

Trial ID

NCT00197002

Treatments Being Tested

GSK Biologicals 2-dose inactivated hepatitis A vaccine (Havrix)Prevnar™

Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age

PHASE2

The purpose of this observer blinded study is to provide information on vac...

Status

Completed

Location

GSK Investigational Site

Start Date

2007-11-20

Trial ID

NCT00578175

Treatments Being Tested

Priorix-Tetra™ (MMRV vaccine 208136)ProQuad®Havrix®Prevnar®

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children

PHASE3

The purpose of this study is to evaluate the efficacy, immunogenicity and s...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-10-01

Trial ID

NCT01439360

Treatments Being Tested

Quadrivalent seasonal influenza vaccine(Flu D-QIV) GSK2321138A Havrix Junior Prevenar 13 Varivax/ProVarivax Varilrix

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

PHASE3

The purpose of this study was to compare the immunogenicity and describe th...

Status

Completed

Location

Birmingham Pediatric Associates Site Number : 8400026

Start Date

2018-04-25

Trial ID

NCT03537508

Treatments Being Tested

MenACYW conjugate vaccine MenACYW-135 conjugate vaccine DTaP-IPV//Hib vaccine Pneumococcal 13-valent conjugate vaccine Pentavalent rotavirus vaccine Hepatitis B vaccine Measles, mumps, rubella (MMR) vaccine Varicella vaccine Hepatitis A vaccine

Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®

PHASE4

The purpose of this study is to assess the long-term persistence of immunit...

Status

Withdrawn

Location

GSK Investigational Site

Start Date

2015-05

Trial ID

NCT02124785

Treatments Being Tested

Blood sampling

Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children

PHASE3

This is a study to evaluate the immune response and safety of GSK Biologica...

Status

Completed

Location

GSK Investigational Site

Start Date

2003-10-06

Trial ID

NCT00197015

Treatments Being Tested

Havrix®M-M-R®II VARIVAX®

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years

PHASE3

The purpose of this study is to evaluate the immunogenicity and safety of t...

Status

Withdrawn

Location

Multiple Locations

Start Date

2015-02

Trial ID

NCT02082639

Treatments Being Tested

Cervarix™Havrix

Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age

PHASE3

The purpose of this study is to evaluate the safety, reactogenicity and imm...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-02-01

Trial ID

NCT01978093

Treatments Being Tested

Hib-MenCY-TT (MenHibrix®)Pediarix®Rotarix®Prevnar 13®PedvaxHIB®Havrix®

Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel

PHASE4

This study will evaluate the persistence, immunogenicity and safety of Havr...

Status

Withdrawn

Location

Multiple Locations

Start Date

2018-05-07

Trial ID

NCT03183492

Treatments Being Tested

Havrix®

Previous Next